Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-014094
Filing Date
2020-05-26
Accepted
2020-05-26 06:05:19
Documents
1
Period of Report
2020-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4577
  Complete submission text file 0000899243-20-014094.txt   6121
Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
PureTech Health LLC (Reporting) CIK: 0001727395 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38958 | Film No.: 20907946

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations